<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>17</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>04</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Isolation and Structure Elucidation, Molecular Docking Studies of Screlotiumol from Soil Borne Fungi Screlotium rolfsii and their Reversal of Multidrug Resistance in Mouse Lymphoma Cells</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>2083</FirstPage>
			<LastPage>2087</LastPage>
			<ELocationID EIdType="pii">32356</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Bashir </FirstName>
					<LastName>Ahmad</LastName>
<Affiliation>Center of Biotechnology and Microbiology, University of Peshawar, Peshawar, Pakistan</Affiliation>

</Author>
<Author>
					<FirstName>Muhammad </FirstName>
					<LastName>Rizwan</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Muslim </FirstName>
					<LastName>Raza</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Sadiq </FirstName>
					<LastName>Azam</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Shumaila </FirstName>
					<LastName>Bashir</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Joseph </FirstName>
					<LastName>Molnar</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Akos </FirstName>
					<LastName>Csonka</LastName>
<Affiliation></Affiliation>

</Author>
<Author>
					<FirstName>Diana </FirstName>
					<LastName>Szabo</LastName>
<Affiliation></Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>A new compound namely (13-(3,3-dihydroxypropyl)-1,6-dihydroxy-3,4-dihydro-1H-isochromen-8(5H)-one (1) was isolated from an ethyl acetate extract of the borne fungi Screlotium rolfsii. Its chemical structure was elucidated by spectroscopic analysis. Screlotiumol 1 were evaluated for their effects on the reversion of multidrug resistant (MDR) mediated by P-glycoprotein (P-gp) of the soil borne fungi. The multidrug resistant P-glycoprotein is a target for chemotherapeutic drugs in cancer cells. In the present study rhodamine-123 exclusion screening test on human mdr1 gene transfected mouse gene transfected L5178 and L5178Y mouse T-cell lymphoma which showed excellent MDR reversing effect in a dose dependent manner against mouse T-lymphoma cell line. Moreover, molecular docking studies of compound-1 also showed better results as compared with the standard. Therefore the preliminary results obtained from this study suggest that screlotiumol 1 could be used as a potential agent for the treatment of cancer.</Abstract>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_32356_041f38ca3fe964dc4f302d7439b2d37b.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
